对转化生长因子-β1抑制的反应可能是治疗心脏纤维化的一个新的治疗靶点。 - Suppr | 超能文献

Response to inhibition of TGF-β1 might be a novel therapeutic target in the treatment of cardiac fibrosis.

作者信息

Liu Jincheng, Wang Feng, Xie Meilin, Chen Rong

机构信息

Department of Pharmacology, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, Jiangsu Province, China; Department of Pharmacy, The First People's Hospital of Jingmen, Jingmen 448000, Hubei Province, China.

Department of Pharmacology, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, Jiangsu Province, China.

出版信息

Int J Cardiol. 2018 Apr 1;256:20. doi: 10.1016/j.ijcard.2017.08.064.

DOI:10.1016/j.ijcard.2017.08.064

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Response to inhibition of TGF-β1 might be a novel therapeutic target in the treatment of cardiac fibrosis.对转化生长因子-β1抑制的反应可能是治疗心脏纤维化的一个新的治疗靶点。

Int J Cardiol. 2018 Apr 1;256:20. doi: 10.1016/j.ijcard.2017.08.064.

2

Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.Notch3通过抑制TGF-β1/Smad3信号通路改善心肌梗死后的心脏纤维化。

Cardiovasc Toxicol. 2016 Oct;16(4):316-24. doi: 10.1007/s12012-015-9341-z.

3

Knockdown of eIF3a ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway.抑制真核翻译起始因子3a（eIF3a）可通过抑制转化生长因子-β1（TGF-β1）/Smad3信号通路改善心脏纤维化。

Cell Mol Biol (Noisy-le-grand). 2016 Jun 30;62(7):97-101.

4

Inhibition of TGF-β1 might be a novel therapeutic target in the treatment of cardiac fibrosis.抑制转化生长因子-β1可能是治疗心脏纤维化的一个新的治疗靶点。

Int J Cardiol. 2018 Apr 1;256:19. doi: 10.1016/j.ijcard.2017.08.021.

5

Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.阿托伐他汀抑制转化生长因子-β1诱导的心肌成纤维细胞内皮糖蛋白表达的机制。

Eur J Heart Fail. 2010 Mar;12(3):219-26. doi: 10.1093/eurjhf/hfq011.

6

CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.CTRP3通过靶向Smad3激活并抑制肌成纤维细胞分化来减轻梗死后心脏纤维化。

J Mol Med (Berl). 2015 Dec;93(12):1311-25. doi: 10.1007/s00109-015-1309-8. Epub 2015 Jul 3.

7

ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.ERK5 抑制通过调节 Smad3 乙酰化改善肺纤维化。

Am J Pathol. 2013 Dec;183(6):1758-1768. doi: 10.1016/j.ajpath.2013.08.014. Epub 2013 Oct 1.

8

Specific α7 nicotinic acetylcholine receptor agonist ameliorates isoproterenol-induced cardiac remodelling in mice through TGF-β1/Smad3 pathway.特异性α7烟碱型乙酰胆碱受体激动剂通过TGF-β1/Smad3信号通路改善异丙肾上腺素诱导的小鼠心脏重塑。

Clin Exp Pharmacol Physiol. 2017 Dec;44(12):1192-1200. doi: 10.1111/1440-1681.12819. Epub 2017 Sep 18.

9

Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model.二肽基肽酶4抑制剂通过抑制高脂饮食诱导的肥胖大鼠模型中的转化生长因子-β1和Smad2/3信号通路减轻肥胖诱导的心肌纤维化。

Metabolism. 2017 Nov;76:42-55. doi: 10.1016/j.metabol.2017.07.007. Epub 2017 Jul 31.

10

Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway.二甲双胍通过抑制 TGFβ1-Smad3 信号通路减轻心脏纤维化。

Cardiovasc Res. 2010 Aug 1;87(3):504-13. doi: 10.1093/cvr/cvq066. Epub 2010 Mar 3.

引用本文的文献

1

Mesenchymal Stem Cells Attenuates TGF-β1-Induced EMT by Increasing HGF Expression in HK-2 Cells.间充质干细胞通过增加HK-2细胞中肝细胞生长因子的表达来减弱转化生长因子-β1诱导的上皮-间质转化。

Iran J Public Health. 2021 May;50(5):908-918. doi: 10.18502/ijph.v50i5.6108.

2

Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-β1/smad3.沉默TRIP13通过激活TGF-β1/smad3抑制肝细胞癌的细胞生长和转移。

Cancer Cell Int. 2018 Dec 17;18:208. doi: 10.1186/s12935-018-0704-y. eCollection 2018.